A Benefit–Risk Analysis Approach to Capture Regulatory Decision-Making: Multiple Myeloma [11/20/17] Raju, Gurumurthi, Domike, Kazandjian, @DrOlaLandgren @BlumenthalG Farrell, @realrickpazdur Woodcock CPT https://t.co/dlbeSGVMuc #mmsm #caxtx @FDAOncology
"Modern combination therapies seem to have enabled a significant increase in median overall survival since the start of the 21st century... If regulatory decisions had to wait for OS results prior to approval of MM drugs, the estimated improvement in me…
A Benefit–Risk Analysis Approach to Capture Regulatory Decision-Making: Multiple Myeloma [11/20/17] Raju, Gurumurthi, Domike, Kazandjian, @DrOlaLandgren @BlumenthalG Farrell, @realrickpazdur Woodcock CPT https://t.co/dlbeSGVMuc #mmsm #caxtx @FDAOncology